European paediatric clinical trials miss priority needs, warns reviewBMJ 2008; 337 doi: https://doi.org/10.1136/bmj.a1551 (Published 03 September 2008) Cite this as: BMJ 2008;337:a1551
- Michael Day
Key studies that are needed to assess the efficacy and safety of medicines in children are not being done, according to a major review of clinical trials in Europe which shows that few studies are being carried out in priority areas.
A research group at the Mario Negri Pharmacological Research Institute in Milan, Italy, reviewed all paediatric clinical trials carried out from 2004 to 2007, after identifying them from a literature search.
The 379 paediatric trials being carried out in the European Union during this period dealt with only four of the 25 priority conditions identified by the European Medicines Agency …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial